Positive data from Provectus Pharmaceuticals' psoriasis and atopic dermatitis trials

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company’s PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.

More... (http://www.news-medical.net/news/20091201/Positive-data-from-Provectus-Pharmaceuticals-psoriasis-and-atopic-dermatitis-trials.aspx)